義合控股(01662.HK)擬折讓約12.96%配售最多1500萬股 淨籌3497萬港元
格隆匯9月16日丨義合控股(01662.HK)公告,於2025年9月15日,公司與配售代理已訂立配售協議,據此,公司已經有條件同意透過配售代理按盡力基準,按配售價每股配售股份港幣2.35元配售最多達1500萬股配售股份予不少於六名承配人(目前預期),而彼等爲獨立第三方。
配售股份最高數目相當於於本公告日期已發行股份總數的3.00%;配售價每股配售股份港幣2.35元較股份於配售協議日期在聯交所所報的收市價每股港幣2.70元折讓約12.96%;假設所有配售股份獲悉數配售,配售事項的所得款項總額及所得款項淨額(經扣除配售事項的傭金及其他開支後)將分別約爲港幣3525萬元及港幣3497萬元,相當於淨髮行價爲每股配售股份約港幣2.33元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.